Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.
about
Effector, Memory, and Dysfunctional CD8(+) T Cell Fates in the Antitumor Immune ResponseTargeting microRNAs as key modulators of tumor immune responseMicroRNAs: Novel immunotherapeutic targets in colorectal carcinomaTrial Watch: Adoptive cell transfer for oncological indicationsA Human Trypanosome Suppresses CD8+ T Cell Priming by Dendritic Cells through the Induction of Immune Regulatory CD4+ Foxp3+ T CellsLoss of PRDM1/BLIMP-1 function contributes to poor prognosis of activated B-cell-like diffuse large B-cell lymphoma.Study design and data analysis considerations for the discovery of prognostic molecular biomarkers: a case study of progression free survival in advanced serous ovarian cancer.MicroRNA miR-23a cluster promotes osteocyte differentiation by regulating TGF-β signalling in osteoblasts.Single vs. combination immunotherapeutic strategies for glioma.An update on miRNAs as biological and clinical determinants in colorectal cancer: a bench-to-bedside approach.T-cell exhaustion in the tumor microenvironment.miR-23∼27∼24 clusters control effector T cell differentiation and function.Enhancing adoptive T cell immunotherapy with microRNA therapeutics.Emerging immunotherapies for glioblastomaMicroRNA-491 regulates the proliferation and apoptosis of CD8(+) T cellsThe Poly-cistronic miR-23-27-24 Complexes Target Endothelial Cell Junctions: Differential Functional and Molecular Effects of miR-23a and miR-23b.Effects of MicroRNA-23a on Differentiation and Gene Expression Profiles in 3T3-L1 Adipocytes.microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.Biological Response Modifier in Cancer Immunotherapy.Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy.MicroRNA-23a Curbs Necrosis during Early T Cell Activation by Enforcing Intracellular Reactive Oxygen Species EquilibriummiR-23a blockade enhances adoptive T cell transfer therapy by preserving immune-competence in the tumor microenvironment.The cholesterol metabolite 27 hydroxycholesterol facilitates breast cancer metastasis through its actions on immune cells.The tumor microenvironment disarms CD8+ T lymphocyte function via a miR-26a-EZH2 axis.The MicroRNA miR-191 Supports T Cell Survival Following Common γ Chain SignalingThe emerging role of miRNAs in combined cancer therapy.Diagnostic and therapeutic applications of miRNA-based strategies to cancer immunotherapy.MicroRNAs in the Diagnosis and Treatment of Cancer.TGF-β in T Cell Biology: Implications for Cancer Immunotherapy.MicroRNA-133a downregulated EGFR expression in human non-small cell lung cancer cells via AKT/ERK signalingMicroRNAs: Pleiotropic Regulators in the Tumor Microenvironment
P2860
Q26744527-A9B3DFEA-60DA-4544-8C00-8216176DB7ECQ26746972-3244B01F-C6B7-40C6-A5C2-8C5E010F8C05Q26747339-538DE522-E2A9-4525-B832-659400D0A2C2Q26785545-938C5D7F-4669-4071-B789-2035B7B5B950Q27313504-3A7673A6-BAA7-46E2-AE27-AEED1836F79AQ27853399-DA870EB9-AAD5-4C4B-9821-FAC9F7857E46Q31106856-54A71A2A-9F9C-41EC-B039-1F18A4C2454EQ33571954-70CE2350-BEC1-4250-B2C7-C0AD0D2BAC6CQ33746041-97D58A3E-4878-4A8F-B3BC-1337C0DFE897Q35811250-1A9972FF-2191-41A1-804E-9CF2422A26A2Q36347369-5F298150-A7AC-4FF6-A516-0BC1DF9FE027Q36569356-DD7ADA5F-1106-4753-9133-4702FD85010CQ36889204-C269F015-C69C-43CB-9E6F-026A03117BA8Q37025105-05CDB3A5-1ADB-4215-9DE2-7D5B700083C6Q37147870-12E3A375-66F0-4EC6-9F37-D3E22C7513BBQ37256210-2F8A9CD6-7E8C-43B6-B8BB-08FC9560EA87Q37373653-FCD4BE29-140C-4FBB-BD22-26BE57729D5AQ38376771-E97141C7-56A5-48DB-9E32-04A2A23BB31DQ38848213-E73CD649-0D74-4CC6-8320-7AEE1196D1D0Q38988078-3BD72491-CFDB-4A54-BCFD-7562700B7539Q39051723-54FFC8B6-9D01-4497-92A7-A1B0088CEE3CQ39276868-DAD35DB3-5131-411B-9215-E6CCD9E98269Q42155981-80D65A72-7D8E-4130-B6BC-67AA34BE453EQ42333838-3F9F75A0-3960-4BD1-A366-C9F883B67984Q42733320-EED46C07-D76C-40F6-B318-0A32F8C1CE9BQ45281926-56F0D078-354A-4D21-968F-829DF8F018E8Q47767814-D362CF7F-F00B-471B-BA2C-434CE802C19AQ50067809-367F6E03-EEE8-4410-A61A-CDC3CF1F98EAQ55515390-E679AC0D-A8A6-42B0-B4DF-EFCDE867665DQ58573308-0767DF74-64A9-4F49-A0A2-3859336ADFCFQ59137767-A6314B00-F899-44A0-8630-D433CF1A0415
P2860
Targeting miR-23a in CD8+ cytotoxic T lymphocytes prevents tumor-dependent immunosuppression.
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@ast
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@en
type
label
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@ast
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@en
prefLabel
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@ast
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@en
P2093
P2860
P356
P1476
Targeting miR-23a in CD8+ cyto ...... r-dependent immunosuppression.
@en
P2093
Chunyan Hu
Jose Sevilla
Qi-Jing Li
Regina Lin
Shan Jiang
P2860
P304
P356
10.1172/JCI76561
P407
P50
P577
2014-10-27T00:00:00Z